Oral inhibitor of phosphorylated-p68 RNA helicase marks Rexahn’s third oncology compound in clinical development

Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Rexahn Pharmaceuticals, Inc. Charts.
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Rexahn Pharmaceuticals, Inc. Charts.